Vericel (VCEL) Revenue (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.36% |
| Dec 31, 2025 | 37.65% |
| Sep 30, 2025 | 6.74% |
| Jun 30, 2025 | 20.23% |
| Mar 31, 2025 | -30.22% |
| Dec 31, 2024 | 30.17% |
| Sep 30, 2024 | 9.96% |
| Jun 30, 2024 | 2.69% |
| Mar 31, 2024 | -21.10% |
| Dec 31, 2023 | 42.59% |
| Sep 30, 2023 | -0.74% |
| Jun 30, 2023 | 11.96% |
| Mar 31, 2023 | -22.16% |
| Dec 31, 2022 | 36.69% |
| Sep 30, 2022 | 4.06% |
| Jun 30, 2022 | 3.33% |
| Mar 31, 2022 | -24.67% |
| Dec 31, 2021 | 37.92% |
| Sep 30, 2021 | -12.69% |
| Jun 30, 2021 | 17.52% |
| Mar 31, 2021 | -25.65% |
| Dec 31, 2020 | 40.21% |
| Sep 30, 2020 | 61.18% |
| Jun 30, 2020 | -24.98% |
| Mar 31, 2020 | -32.27% |
| Dec 31, 2019 | 29.15% |
| Sep 30, 2019 | 16.63% |
| Jun 30, 2019 | 19.90% |
| Mar 31, 2019 | -30.40% |
| Dec 31, 2018 | 39.37% |
| Sep 30, 2018 | 18.27% |
| Jun 30, 2018 | 5.46% |
| Mar 31, 2018 | -22.80% |
| Dec 31, 2017 | 63.74% |
| Sep 30, 2017 | -15.89% |
| Jun 30, 2017 | 81.10% |
| Mar 31, 2017 | -59.91% |
| Dec 31, 2016 | 113.65% |
| Sep 30, 2016 | -14.77% |
| Jun 30, 2016 | -9.11% |
| Mar 31, 2016 | -8.51% |
| Dec 31, 2015 | 36.35% |
| Sep 30, 2015 | -16.78% |
| Jun 30, 2015 | 25.27% |
| Mar 31, 2015 | -26.23% |
| Dec 31, 2014 | 52.27% |
| Sep 30, 2014 | 117.92% |
| Jun 30, 2013 | -62.50% |
| Mar 31, 2013 | -57.89% |